Molly Henderson - Apr 6, 2023 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Signature
/s/ Larry Miller, Attorney-in-Fact for Molly Henderson
Stock symbol
PHAT
Transactions as of
Apr 6, 2023
Transactions value $
-$25,002
Form type
4
Date filed
4/7/2023, 03:18 PM
Previous filing
Mar 3, 2023
Next filing
May 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHAT Common Stock Sale -$25K -3.44K -4.52% $7.27 72.6K Apr 6, 2023 Direct F1, F2
holding PHAT Common Stock 339 Apr 6, 2023 by 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 28, 2022.
F2 Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.